Intuitive Surgical, Inc. (NASDAQ:ISRG) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRGGet Rating) have been given an average rating of “Moderate Buy” by the twenty-four research firms that are covering the firm, MarketBeat.com reports. Eight investment analysts have rated the stock with a hold recommendation and eleven have assigned a buy recommendation to the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $261.05.

A number of research analysts have weighed in on ISRG shares. Raymond James decreased their target price on shares of Intuitive Surgical from $294.00 to $255.00 in a research note on Friday, July 22nd. Jefferies Financial Group began coverage on shares of Intuitive Surgical in a research note on Wednesday, October 12th. They issued a “hold” rating and a $210.00 price target for the company. Barclays began coverage on shares of Intuitive Surgical in a research note on Monday, October 17th. They issued an “overweight” rating and a $235.00 price target for the company. StockNews.com began coverage on shares of Intuitive Surgical in a research note on Wednesday, October 12th. They issued a “hold” rating for the company. Finally, Mizuho began coverage on shares of Intuitive Surgical in a research note on Wednesday, October 12th. They set a “neutral” rating and a $215.00 target price for the company.

Intuitive Surgical Trading Up 0.5 %

Shares of ISRG opened at $262.11 on Friday. Intuitive Surgical has a 12 month low of $180.07 and a 12 month high of $369.21. The stock has a fifty day moving average price of $217.25 and a 200-day moving average price of $216.86. The firm has a market cap of $92.63 billion, a PE ratio of 69.16, a P/E/G ratio of 5.80 and a beta of 1.38.

Intuitive Surgical (NASDAQ:ISRGGet Rating) last issued its earnings results on Tuesday, October 18th. The medical equipment provider reported $1.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.12 by $0.07. Intuitive Surgical had a return on equity of 11.54% and a net margin of 22.52%. The company had revenue of $1.56 billion during the quarter, compared to analyst estimates of $1.52 billion. During the same quarter last year, the business posted $1.04 EPS. The firm’s quarterly revenue was up 11.0% on a year-over-year basis. As a group, research analysts forecast that Intuitive Surgical will post 3.79 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In related news, Director Amal M. Johnson sold 6,375 shares of the firm’s stock in a transaction on Thursday, September 8th. The stock was sold at an average price of $210.76, for a total value of $1,343,595.00. Following the transaction, the director now owns 11,224 shares in the company, valued at $2,365,570.24. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Intuitive Surgical news, Director Amal M. Johnson sold 6,375 shares of Intuitive Surgical stock in a transaction dated Thursday, September 8th. The stock was sold at an average price of $210.76, for a total value of $1,343,595.00. Following the transaction, the director now owns 11,224 shares in the company, valued at $2,365,570.24. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Myriam Curet sold 8,000 shares of the business’s stock in a transaction dated Friday, October 21st. The stock was sold at an average price of $209.78, for a total value of $1,678,240.00. Following the sale, the executive vice president now owns 217 shares in the company, valued at $45,522.26. The disclosure for this sale can be found here. Insiders sold 72,953 shares of company stock valued at $15,867,996 in the last quarter. 0.90% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Intuitive Surgical

Institutional investors have recently modified their holdings of the company. Jennison Associates LLC lifted its position in shares of Intuitive Surgical by 124.8% during the 1st quarter. Jennison Associates LLC now owns 5,473,854 shares of the medical equipment provider’s stock valued at $1,651,352,000 after buying an additional 3,038,455 shares during the last quarter. Edgewood Management LLC grew its position in Intuitive Surgical by 20.3% during the 1st quarter. Edgewood Management LLC now owns 8,902,682 shares of the medical equipment provider’s stock worth $2,685,761,000 after acquiring an additional 1,504,353 shares during the last quarter. BlackRock Inc. grew its position in Intuitive Surgical by 5.6% during the 3rd quarter. BlackRock Inc. now owns 27,887,777 shares of the medical equipment provider’s stock worth $5,227,284,000 after acquiring an additional 1,477,885 shares during the last quarter. Price T Rowe Associates Inc. MD grew its position in shares of Intuitive Surgical by 3.3% in the 2nd quarter. Price T Rowe Associates Inc. MD now owns 25,692,735 shares of the medical equipment provider’s stock worth $5,156,788,000 after buying an additional 816,066 shares during the last quarter. Finally, Goldman Sachs Group Inc. lifted its stake in shares of Intuitive Surgical by 49.0% in the 2nd quarter. Goldman Sachs Group Inc. now owns 1,888,228 shares of the medical equipment provider’s stock valued at $378,987,000 after purchasing an additional 621,063 shares during the period. 82.44% of the stock is owned by institutional investors and hedge funds.

About Intuitive Surgical

(Get Rating)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

See Also

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.